These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12426309)

  • 41. Combining mutations that modulate inter-subunit interactions and proteolytic inactivation enhance the stability of factor VIIIa.
    Wakabayashi H; Wintermute JM; Fay PJ
    Thromb Haemost; 2014 Jul; 112(1):43-52. PubMed ID: 24599523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa.
    Pipe SW; Saenko EL; Eickhorst AN; Kemball-Cook G; Kaufman RJ
    Blood; 2001 Feb; 97(3):685-91. PubMed ID: 11157485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex.
    Jenkins PV; Freas J; Schmidt KM; Zhou Q; Fay PJ
    Blood; 2002 Jul; 100(2):501-8. PubMed ID: 12091341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics of the interaction between the human factor VIIIa subunits: effects of pH, ionic strength, Ca2+ concentration, heparin, and activated protein C-catalyzed proteolysis.
    Persson E; Ezban M; Shymko RM
    Biochemistry; 1995 Oct; 34(39):12775-81. PubMed ID: 7548032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
    Ahmad SS; Walsh PN
    Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of plasmin-interactive sites in the light chain of factor VIII responsible for proteolytic cleavage at Lys36.
    Nogami K; Nishiya K; Saenko EL; Takeyama M; Ogiwara K; Yoshioka A; Shima M
    J Biol Chem; 2009 Mar; 284(11):6934-45. PubMed ID: 19126539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sequences flanking Arg336 in factor VIIIa modulate factor Xa-catalyzed cleavage rates at this site and cofactor function.
    DeAngelis JP; Wakabayashi H; Fay PJ
    J Biol Chem; 2012 May; 287(19):15409-17. PubMed ID: 22411993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular orientation of factor VIIIa on the phospholipid membrane surface determined by fluorescence resonance energy transfer.
    Wakabayashi H; Fay PJ
    Biochem J; 2013 Jun; 452(2):293-301. PubMed ID: 23521092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subunit structure and function of porcine factor Xa-activated factor VIII.
    Parker ET; Pohl J; Blackburn MN; Lollar P
    Biochemistry; 1997 Aug; 36(31):9365-73. PubMed ID: 9235979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factor VIII structure and function.
    Fay PJ
    Int J Hematol; 2006 Feb; 83(2):103-8. PubMed ID: 16513527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation.
    Parker ET; Lollar P
    Biochemistry; 2007 Aug; 46(34):9737-42. PubMed ID: 17676877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Residues surrounding Arg336 and Arg562 contribute to the disparate rates of proteolysis of factor VIIIa catalyzed by activated protein C.
    Varfaj F; Wakabayashi H; Fay PJ
    J Biol Chem; 2007 Jul; 282(28):20264-72. PubMed ID: 17519239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mn2+ binding to factor VIII subunits and its effect on cofactor activity.
    Wakabayashi H; Zhen Z; Schmidt KM; Fay PJ
    Biochemistry; 2003 Jan; 42(1):145-53. PubMed ID: 12515549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of hydrophobic mutations on the binding affinity and stability of blood coagulation factor VIIIa: a computational molecular dynamics and free-energy analysis.
    Venkateswarlu D
    Biochem Biophys Res Commun; 2014 Jul; 450(1):735-40. PubMed ID: 24952158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variable contributions of basic residues forming an APC exosite in the binding and inactivation of factor VIIIa.
    Takeyama M; Wintermute JM; Manithody C; Rezaie AR; Fay PJ
    Biochemistry; 2013 Apr; 52(13):2228-35. PubMed ID: 23480827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exosite-interactive regions in the A1 and A2 domains of factor VIII facilitate thrombin-catalyzed cleavage of heavy chain.
    Nogami K; Zhou Q; Myles T; Leung LL; Wakabayashi H; Fay PJ
    J Biol Chem; 2005 May; 280(18):18476-87. PubMed ID: 15746105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coagulant properties of hybrid human/porcine factor VIII molecules.
    Lollar P; Parker ET; Fay PJ
    J Biol Chem; 1992 Nov; 267(33):23652-7. PubMed ID: 1429706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms that regulate the anticoagulant function of coagulation factor V.
    Thorelli E
    Scand J Clin Lab Invest Suppl; 1999; 229():19-26. PubMed ID: 10097286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factor VIII A3 domain residues 1954-1961 represent an A1 domain-interactive site.
    Ansong C; Fay PJ
    Biochemistry; 2005 Jun; 44(24):8850-7. PubMed ID: 15952791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.